ENGN Stock Analysis: Buy, Sell, or Hold?
ENGN - enGene Holdings Inc. Common Stock
$9.53
-0.74 (-7.21%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 09, 2026
Get Alerted When ENGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called ENGN this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ENGN is down 21.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ENGN is down 21.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ENGN is currently trading at $9.53, which is considered fair relative to its 30-day fair value range of $8.44 to $10.43.
Technical Outlook: Technically, ENGN is in a uptrend. Immediate support is located at $8.68, while resistance sits at $12.25. Short-term momentum is weak, with the stock down 7.2% recently.
Market Sentiment: ENGN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $23.50 (+146.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ENGN is in a uptrend. Immediate support is located at $8.68, while resistance sits at $12.25. Short-term momentum is weak, with the stock down 7.2% recently.
Market Sentiment: ENGN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $23.50 (+146.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$8.44 -
$10.43
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
81.6%
Protect Your Profits
Holding ENGN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.2%)
- BULLISH: Trading 146.6% below Wall St target ($23.50)
- WARNING: Recommendation downgraded due to -21.7% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$8.44 -
$10.43
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$8.68
Resistance Level
$12.25
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-4.72
Wall Street Target
$23.50
(+146.6%)
Last updated: February 01, 2026 12:15 PM ET
Data refreshes hourly during market hours. Next update: 1:15 PM
Data refreshes hourly during market hours. Next update: 1:15 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ENGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 63 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 55 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 53 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 62 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 55 HOLD |
Advanced ENGN Option Strategies
Professional options setups generated by AI based on today's ENGN price and gamma walls.
